How much does neratinib/neratinib cost in India
Neratinib/Neratinib is an oral, irreversible tyrosine kinase inhibitor mainly used to treat HER2 (human epidermal growth factor receptor-2)-positive breast cancer. This drug is particularly suitable for breast cancer patients who have completed standard adjuvant trastuzumab therapy and whose disease has not progressed but who have high-risk factors. Neratinib, as intensive adjuvant therapy after chemotherapy and trastuzumab, reduces the rate of clinically significant breast cancer recurrence, including recurrences that may lead to death, such as distant and local recurrences, without increasing the risk of long-term toxicity.

Neratinib may be commercially available in India. As a world-renowned pharmaceutical manufacturer and exporter, India has an extensive pharmaceutical market, including a variety of anti-cancer drugs. Currently, generic drugs of neratinib are also sold overseas. Its pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. However, there is no Indian version of the generic drug. Common generic drug manufacturers include Bangladesh Beacon Pharmaceuticals, Bangladesh Yaopin International, etc. When purchasing medicines, make sure to purchase them from formal channels and pay attention to check the quality and authenticity of the medicines. In addition, since this drug is a prescription drug, you need to bring a doctor's prescription certificate when purchasing it.
The original drug neratinib has been launched and is included in Class B medical insurance, but it is only reimbursed for patients with indications. Its specifications are40mg*180 tablets per box, and the price is about 7,000 yuan. In comparison, the original drug of neratinib marketed overseas is more expensive, which may be as high as more than 10,000 US dollars per box. The medicines produced by Bangladesh Yaopin International Pharmaceutical Factory are 40mg*180 tablets per box, and the price is about more than 3,000 yuan (the price may fluctuate due to the exchange rate).
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)